In addition, serum MIP-1α levels has been reported to be higher in AS patients than those in rheumatoid arthritis (RA) patients and healthy controls, and anti-TNFα therapy appeared to reduce serum MIP-1α levels though with lower efficacy in AS than in RA patients28. The gene discussed is TNF; the disease is rheumatoid arthritis.